| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Tract Infections | 13 | 2021 | 805 | 1.440 |
Why?
|
| Vesico-Ureteral Reflux | 11 | 2023 | 434 | 1.360 |
Why?
|
| Urinary Bladder | 8 | 2021 | 1154 | 0.630 |
Why?
|
| Hydronephrosis | 5 | 2023 | 274 | 0.540 |
Why?
|
| Urography | 2 | 2015 | 316 | 0.540 |
Why?
|
| Hypospadias | 3 | 2023 | 97 | 0.500 |
Why?
|
| Bladder Exstrophy | 3 | 2023 | 107 | 0.450 |
Why?
|
| Dog Diseases | 1 | 2013 | 142 | 0.400 |
Why?
|
| Circumcision, Male | 3 | 2023 | 148 | 0.380 |
Why?
|
| Cryptorchidism | 2 | 2023 | 152 | 0.380 |
Why?
|
| Autoantibodies | 4 | 2013 | 2113 | 0.370 |
Why?
|
| Optic Nerve | 1 | 2013 | 567 | 0.320 |
Why?
|
| Cicatrix | 3 | 2020 | 798 | 0.320 |
Why?
|
| Urinary Tract | 3 | 2023 | 305 | 0.320 |
Why?
|
| Urologic Surgical Procedures | 5 | 2024 | 281 | 0.310 |
Why?
|
| Urinary Bladder, Neurogenic | 2 | 2024 | 176 | 0.310 |
Why?
|
| Spinal Dysraphism | 2 | 2024 | 179 | 0.290 |
Why?
|
| Infertility, Male | 2 | 2023 | 395 | 0.270 |
Why?
|
| Radionuclide Imaging | 2 | 2021 | 1978 | 0.260 |
Why?
|
| Protein Array Analysis | 4 | 2013 | 399 | 0.260 |
Why?
|
| Mass Screening | 5 | 2020 | 5446 | 0.260 |
Why?
|
| Hospitals, Pediatric | 5 | 2024 | 1846 | 0.250 |
Why?
|
| Antibiotic Prophylaxis | 3 | 2022 | 644 | 0.250 |
Why?
|
| Replantation | 2 | 2016 | 146 | 0.240 |
Why?
|
| Salmonella typhi | 3 | 2011 | 201 | 0.230 |
Why?
|
| Urologic Diseases | 2 | 2019 | 245 | 0.230 |
Why?
|
| Dilatation, Pathologic | 3 | 2023 | 527 | 0.230 |
Why?
|
| Ureter | 2 | 2016 | 364 | 0.220 |
Why?
|
| Ureteroscopy | 3 | 2022 | 140 | 0.210 |
Why?
|
| Phimosis | 1 | 2023 | 10 | 0.210 |
Why?
|
| Glaucoma | 1 | 2013 | 1194 | 0.210 |
Why?
|
| Varicocele | 1 | 2023 | 75 | 0.210 |
Why?
|
| Lithotripsy, Laser | 1 | 2022 | 44 | 0.200 |
Why?
|
| Orchiectomy | 2 | 2021 | 460 | 0.190 |
Why?
|
| Kidney | 5 | 2021 | 7066 | 0.190 |
Why?
|
| Child, Preschool | 24 | 2024 | 42500 | 0.180 |
Why?
|
| Infant | 21 | 2023 | 36386 | 0.180 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2024 | 238 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 4392 | 0.170 |
Why?
|
| Urologic Surgical Procedures, Male | 2 | 2017 | 78 | 0.170 |
Why?
|
| Spermatic Cord Torsion | 1 | 2020 | 70 | 0.170 |
Why?
|
| Child | 33 | 2024 | 80564 | 0.170 |
Why?
|
| Lasers, Solid-State | 1 | 2022 | 183 | 0.170 |
Why?
|
| Typhoid Fever | 2 | 2011 | 197 | 0.160 |
Why?
|
| Kidney Diseases | 2 | 2021 | 2098 | 0.160 |
Why?
|
| Retrospective Studies | 28 | 2024 | 81514 | 0.150 |
Why?
|
| Cerebral Palsy | 1 | 2023 | 481 | 0.150 |
Why?
|
| Keratin-5 | 1 | 2017 | 43 | 0.150 |
Why?
|
| Hernia, Inguinal | 1 | 2020 | 224 | 0.140 |
Why?
|
| Urethral Stricture | 1 | 2017 | 50 | 0.140 |
Why?
|
| Male | 54 | 2024 | 363698 | 0.140 |
Why?
|
| Fluoroscopy | 2 | 2018 | 947 | 0.140 |
Why?
|
| Nurse Practitioners | 1 | 2020 | 272 | 0.140 |
Why?
|
| Ultrasonography, Doppler | 1 | 2019 | 460 | 0.140 |
Why?
|
| Mood Disorders | 2 | 2013 | 1128 | 0.130 |
Why?
|
| Ultrasonography | 7 | 2021 | 5993 | 0.130 |
Why?
|
| Sacrococcygeal Region | 1 | 2016 | 52 | 0.130 |
Why?
|
| Sperm Retrieval | 1 | 2015 | 23 | 0.130 |
Why?
|
| Meningocele | 1 | 2016 | 50 | 0.130 |
Why?
|
| Klinefelter Syndrome | 1 | 2015 | 48 | 0.130 |
Why?
|
| Postoperative Complications | 7 | 2023 | 15747 | 0.120 |
Why?
|
| Urothelium | 1 | 2017 | 272 | 0.120 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 786 | 0.120 |
Why?
|
| Cystostomy | 1 | 2015 | 25 | 0.120 |
Why?
|
| Bacteremia | 3 | 2011 | 989 | 0.120 |
Why?
|
| Kidney Pelvis | 1 | 2016 | 190 | 0.120 |
Why?
|
| Epidemiology | 1 | 2017 | 279 | 0.120 |
Why?
|
| Anti-Allergic Agents | 1 | 2016 | 153 | 0.120 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2014 | 56 | 0.120 |
Why?
|
| Urinary Diversion | 1 | 2015 | 134 | 0.120 |
Why?
|
| Antigens, Bacterial | 2 | 2010 | 1146 | 0.110 |
Why?
|
| Appendix | 1 | 2015 | 109 | 0.110 |
Why?
|
| Humans | 71 | 2024 | 765968 | 0.110 |
Why?
|
| Antibody Specificity | 2 | 2013 | 1061 | 0.110 |
Why?
|
| Sucrose | 1 | 2014 | 155 | 0.110 |
Why?
|
| Female | 47 | 2024 | 396112 | 0.110 |
Why?
|
| Siblings | 2 | 2015 | 828 | 0.110 |
Why?
|
| Adolescent | 24 | 2024 | 88835 | 0.110 |
Why?
|
| Urology | 1 | 2018 | 384 | 0.110 |
Why?
|
| Costs and Cost Analysis | 2 | 2016 | 1668 | 0.110 |
Why?
|
| Peanut Hypersensitivity | 1 | 2016 | 217 | 0.110 |
Why?
|
| Fever of Unknown Origin | 1 | 2013 | 94 | 0.110 |
Why?
|
| Infant, Newborn | 10 | 2020 | 26346 | 0.100 |
Why?
|
| RNA, Bacterial | 2 | 2011 | 392 | 0.100 |
Why?
|
| Anaerobic Threshold | 1 | 2012 | 51 | 0.100 |
Why?
|
| Proteomics | 5 | 2021 | 3910 | 0.100 |
Why?
|
| Orchiopexy | 2 | 2023 | 21 | 0.100 |
Why?
|
| Data Mining | 1 | 2017 | 562 | 0.100 |
Why?
|
| Urination | 3 | 2021 | 204 | 0.100 |
Why?
|
| Cephalosporins | 1 | 2013 | 200 | 0.100 |
Why?
|
| Carbohydrates | 1 | 2014 | 386 | 0.100 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2015 | 325 | 0.100 |
Why?
|
| Cholera | 2 | 2009 | 754 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 1268 | 0.100 |
Why?
|
| Lumbosacral Region | 1 | 2013 | 295 | 0.100 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2014 | 615 | 0.100 |
Why?
|
| Diskectomy | 1 | 2013 | 201 | 0.090 |
Why?
|
| Spondylolisthesis | 1 | 2013 | 173 | 0.090 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2015 | 363 | 0.090 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 1774 | 0.090 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2014 | 206 | 0.090 |
Why?
|
| Desensitization, Immunologic | 1 | 2016 | 544 | 0.090 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 255 | 0.090 |
Why?
|
| Bangladesh | 5 | 2011 | 745 | 0.090 |
Why?
|
| Salmonella paratyphi A | 1 | 2010 | 47 | 0.090 |
Why?
|
| Paratyphoid Fever | 1 | 2010 | 34 | 0.090 |
Why?
|
| Penis | 2 | 2023 | 209 | 0.090 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 2021 | 82 | 0.090 |
Why?
|
| Ultrasonography, Mammary | 1 | 2012 | 241 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2014 | 702 | 0.080 |
Why?
|
| Proteome | 1 | 2020 | 1899 | 0.080 |
Why?
|
| Antibodies, Bacterial | 3 | 2010 | 1476 | 0.080 |
Why?
|
| Recurrence | 5 | 2021 | 8501 | 0.080 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2010 | 266 | 0.080 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2009 | 64 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 995 | 0.080 |
Why?
|
| Regeneration | 1 | 2017 | 1517 | 0.080 |
Why?
|
| Medical Records | 1 | 2014 | 1409 | 0.080 |
Why?
|
| Bacterial Proteins | 3 | 2011 | 3837 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 1424 | 0.080 |
Why?
|
| Helminthiasis | 1 | 2009 | 81 | 0.070 |
Why?
|
| Neutropenia | 1 | 2013 | 893 | 0.070 |
Why?
|
| Amino Acids | 1 | 2014 | 1709 | 0.070 |
Why?
|
| Blood | 1 | 2010 | 597 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2011 | 3797 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2013 | 5020 | 0.070 |
Why?
|
| Dogs | 1 | 2013 | 3822 | 0.070 |
Why?
|
| Herpes Zoster | 1 | 2010 | 252 | 0.070 |
Why?
|
| Occupational Exposure | 1 | 2018 | 1805 | 0.070 |
Why?
|
| Documentation | 1 | 2014 | 916 | 0.070 |
Why?
|
| Health Resources | 1 | 2013 | 949 | 0.070 |
Why?
|
| Urine | 2 | 2020 | 360 | 0.070 |
Why?
|
| Incidence | 5 | 2019 | 21480 | 0.070 |
Why?
|
| Salmonella typhimurium | 1 | 2009 | 348 | 0.070 |
Why?
|
| Colon | 1 | 2015 | 1795 | 0.070 |
Why?
|
| Young Adult | 14 | 2021 | 59889 | 0.070 |
Why?
|
| Antigens, Neoplasm | 3 | 2011 | 2002 | 0.070 |
Why?
|
| Antipsychotic Agents | 2 | 2012 | 3076 | 0.070 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2009 | 403 | 0.070 |
Why?
|
| Injections, Intramuscular | 2 | 2024 | 552 | 0.070 |
Why?
|
| Clostridium Infections | 1 | 2013 | 564 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2014 | 2002 | 0.070 |
Why?
|
| Gene Expression Profiling | 6 | 2014 | 9525 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2017 | 3607 | 0.060 |
Why?
|
| Verbal Learning | 1 | 2008 | 461 | 0.060 |
Why?
|
| Vibrio cholerae | 2 | 2009 | 793 | 0.060 |
Why?
|
| Risperidone | 1 | 2008 | 383 | 0.060 |
Why?
|
| Metabolome | 1 | 2012 | 1005 | 0.060 |
Why?
|
| MicroRNAs | 2 | 2013 | 3785 | 0.060 |
Why?
|
| Telemedicine | 1 | 2023 | 3105 | 0.060 |
Why?
|
| Massachusetts | 2 | 2015 | 8875 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2015 | 1950 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 2015 | 2193 | 0.060 |
Why?
|
| Pseudomonas Infections | 1 | 2009 | 622 | 0.060 |
Why?
|
| Quality of Life | 2 | 2017 | 13462 | 0.060 |
Why?
|
| Poverty | 2 | 2013 | 2714 | 0.060 |
Why?
|
| Thiazoles | 1 | 2012 | 1529 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2008 | 459 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 2423 | 0.060 |
Why?
|
| Hematologic Neoplasms | 2 | 2013 | 1927 | 0.060 |
Why?
|
| Spinal Fusion | 1 | 2013 | 1302 | 0.060 |
Why?
|
| Breast | 1 | 2012 | 1946 | 0.050 |
Why?
|
| Transplantation Conditioning | 1 | 2010 | 1635 | 0.050 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2009 | 1141 | 0.050 |
Why?
|
| Breast Neoplasms | 4 | 2012 | 21056 | 0.050 |
Why?
|
| Nicotine | 1 | 2008 | 682 | 0.050 |
Why?
|
| Observer Variation | 2 | 2019 | 2615 | 0.050 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2009 | 790 | 0.050 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 39193 | 0.050 |
Why?
|
| Psychotic Disorders | 2 | 2008 | 3270 | 0.050 |
Why?
|
| Thulium | 1 | 2022 | 21 | 0.050 |
Why?
|
| Holmium | 1 | 2022 | 29 | 0.050 |
Why?
|
| Sperm Count | 1 | 2023 | 227 | 0.050 |
Why?
|
| Double-Blind Method | 5 | 2019 | 12437 | 0.050 |
Why?
|
| Depressive Disorder, Major | 2 | 2012 | 4808 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 15398 | 0.050 |
Why?
|
| Muscle Spasticity | 1 | 2023 | 160 | 0.050 |
Why?
|
| Neuromuscular Agents | 1 | 2024 | 148 | 0.050 |
Why?
|
| Sperm Motility | 1 | 2023 | 265 | 0.050 |
Why?
|
| Dilatation | 1 | 2023 | 310 | 0.050 |
Why?
|
| Health Status | 1 | 2015 | 4080 | 0.050 |
Why?
|
| Mental Recall | 1 | 2008 | 1218 | 0.050 |
Why?
|
| Adult | 21 | 2018 | 223044 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 2844 | 0.050 |
Why?
|
| Mammography | 1 | 2012 | 2423 | 0.050 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2009 | 1276 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 3602 | 0.050 |
Why?
|
| Piperazines | 1 | 2012 | 2549 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2015 | 3286 | 0.050 |
Why?
|
| Semen Analysis | 1 | 2023 | 237 | 0.050 |
Why?
|
| Decision Making | 1 | 2015 | 3965 | 0.050 |
Why?
|
| Schizophrenic Psychology | 1 | 2008 | 1648 | 0.050 |
Why?
|
| Reproducibility of Results | 5 | 2019 | 20124 | 0.040 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 2699 | 0.040 |
Why?
|
| Semen | 1 | 2023 | 354 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8703 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 7478 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 2009 | 1287 | 0.040 |
Why?
|
| Primary Health Care | 2 | 2013 | 4736 | 0.040 |
Why?
|
| Cohort Studies | 6 | 2022 | 41649 | 0.040 |
Why?
|
| Pelvic Pain | 1 | 2021 | 300 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 3446 | 0.040 |
Why?
|
| Bipolar Disorder | 2 | 2013 | 5138 | 0.040 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 26318 | 0.040 |
Why?
|
| Sensitivity and Specificity | 4 | 2020 | 14652 | 0.040 |
Why?
|
| United States | 7 | 2024 | 72903 | 0.040 |
Why?
|
| Sex Factors | 3 | 2019 | 10603 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2019 | 24282 | 0.040 |
Why?
|
| Attention | 1 | 2008 | 2419 | 0.040 |
Why?
|
| Leukocytes | 1 | 2005 | 2027 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4562 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 8923 | 0.040 |
Why?
|
| Pregnancy | 4 | 2023 | 30260 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2015 | 13039 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 2176 | 0.030 |
Why?
|
| Registries | 1 | 2013 | 8297 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2021 | 452 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2019 | 587 | 0.030 |
Why?
|
| Postnatal Care | 1 | 2019 | 275 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2017 | 139 | 0.030 |
Why?
|
| Immunoglobulin A | 2 | 2010 | 995 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2020 | 5302 | 0.030 |
Why?
|
| Microarray Analysis | 2 | 2010 | 752 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2023 | 1055 | 0.030 |
Why?
|
| Syndrome | 1 | 2021 | 3271 | 0.030 |
Why?
|
| Time Factors | 4 | 2020 | 40065 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2023 | 1226 | 0.030 |
Why?
|
| Treatment Outcome | 6 | 2020 | 65188 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2020 | 8733 | 0.030 |
Why?
|
| Lung | 1 | 2013 | 10033 | 0.030 |
Why?
|
| Skin Tests | 1 | 2016 | 630 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 939 | 0.030 |
Why?
|
| Middle Aged | 13 | 2015 | 223009 | 0.030 |
Why?
|
| Reoperation | 2 | 2015 | 4294 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2014 | 287 | 0.030 |
Why?
|
| Peptides | 2 | 2020 | 4331 | 0.030 |
Why?
|
| Budesonide | 1 | 2014 | 163 | 0.030 |
Why?
|
| Fever | 1 | 2021 | 1603 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2015 | 9649 | 0.030 |
Why?
|
| Gene Expression | 1 | 2005 | 7584 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2005 | 2511 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2014 | 322 | 0.030 |
Why?
|
| Chile | 1 | 2013 | 258 | 0.030 |
Why?
|
| Obesity | 1 | 2015 | 13076 | 0.030 |
Why?
|
| Fetal Diseases | 1 | 2018 | 914 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2013 | 12768 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2014 | 398 | 0.020 |
Why?
|
| Palpation | 1 | 2012 | 166 | 0.020 |
Why?
|
| Animals | 6 | 2017 | 168764 | 0.020 |
Why?
|
| General Practitioners | 1 | 2013 | 105 | 0.020 |
Why?
|
| Organogenesis | 1 | 2013 | 213 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 990 | 0.020 |
Why?
|
| Age Factors | 2 | 2019 | 18380 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 433 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2017 | 1162 | 0.020 |
Why?
|
| Neuralgia, Postherpetic | 1 | 2010 | 41 | 0.020 |
Why?
|
| Metaplasia | 1 | 2011 | 326 | 0.020 |
Why?
|
| Cell Count | 1 | 2014 | 1823 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 1481 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2013 | 812 | 0.020 |
Why?
|
| Morbidity | 1 | 2015 | 1749 | 0.020 |
Why?
|
| Lipopolysaccharides | 2 | 2009 | 2216 | 0.020 |
Why?
|
| Herpesvirus 3, Human | 1 | 2010 | 159 | 0.020 |
Why?
|
| Eosinophils | 1 | 2014 | 945 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 3202 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2008 | 6972 | 0.020 |
Why?
|
| Length of Stay | 1 | 2023 | 6485 | 0.020 |
Why?
|
| Reference Values | 1 | 2016 | 4908 | 0.020 |
Why?
|
| Vidarabine | 1 | 2010 | 343 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2010 | 521 | 0.020 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2010 | 196 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 36532 | 0.020 |
Why?
|
| Allergens | 1 | 2016 | 1436 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2017 | 2573 | 0.020 |
Why?
|
| Neprilysin | 1 | 2011 | 484 | 0.020 |
Why?
|
| Virus Activation | 1 | 2010 | 323 | 0.020 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2008 | 80 | 0.020 |
Why?
|
| Infertility | 1 | 2015 | 654 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 2010 | 4528 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2017 | 1855 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2021 | 6255 | 0.020 |
Why?
|
| Risk Factors | 4 | 2015 | 74840 | 0.020 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2008 | 84 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 1984 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2966 | 0.020 |
Why?
|
| Bacterial Vaccines | 1 | 2009 | 400 | 0.020 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2008 | 158 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2008 | 202 | 0.020 |
Why?
|
| Epithelium | 1 | 2011 | 1599 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2021 | 9347 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2021 | 5089 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 2009 | 563 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2008 | 715 | 0.020 |
Why?
|
| Inflammation | 1 | 2005 | 10850 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2013 | 2086 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10563 | 0.020 |
Why?
|
| Virulence | 1 | 2009 | 1289 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2010 | 1528 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1612 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2015 | 22223 | 0.020 |
Why?
|
| Species Specificity | 1 | 2009 | 2406 | 0.010 |
Why?
|
| Mice | 4 | 2017 | 81819 | 0.010 |
Why?
|
| Vitamin A | 1 | 2008 | 610 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1808 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 2228 | 0.010 |
Why?
|
| Boston | 1 | 2017 | 9338 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 12509 | 0.010 |
Why?
|
| Cell Survival | 1 | 2014 | 5747 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 1526 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 2008 | 967 | 0.010 |
Why?
|
| Radiography | 1 | 2015 | 6919 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2009 | 1039 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2900 | 0.010 |
Why?
|
| Zinc | 1 | 2008 | 675 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2009 | 1075 | 0.010 |
Why?
|
| Long QT Syndrome | 1 | 2008 | 474 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 2194 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2008 | 2263 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 2686 | 0.010 |
Why?
|
| ROC Curve | 1 | 2010 | 3620 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 1066 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2013 | 2643 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 7838 | 0.010 |
Why?
|
| Cell Movement | 1 | 2014 | 5194 | 0.010 |
Why?
|
| Arousal | 1 | 2008 | 1171 | 0.010 |
Why?
|
| Age Distribution | 1 | 2008 | 2858 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12056 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 5526 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 4860 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2008 | 2108 | 0.010 |
Why?
|
| Reaction Time | 1 | 2008 | 2086 | 0.010 |
Why?
|
| Acute Disease | 1 | 2012 | 7232 | 0.010 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2008 | 1989 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2010 | 6322 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3807 | 0.010 |
Why?
|
| Hospitals | 1 | 2014 | 3888 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 8067 | 0.010 |
Why?
|
| Prevalence | 1 | 2017 | 15842 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11641 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2015 | 54802 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4850 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2015 | 3853 | 0.010 |
Why?
|
| Spleen | 1 | 2005 | 2296 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2011 | 3681 | 0.010 |
Why?
|
| Aged | 4 | 2013 | 171117 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6499 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2014 | 18973 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10429 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2010 | 3050 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2010 | 3078 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 11206 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 4209 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 2942 | 0.010 |
Why?
|
| Exercise | 1 | 2012 | 5937 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 2717 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 3596 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 7123 | 0.010 |
Why?
|
| Genotype | 1 | 2009 | 13024 | 0.010 |
Why?
|
| Depression | 1 | 2013 | 8237 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 16721 | 0.010 |
Why?
|
| Logistic Models | 1 | 2008 | 13266 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9443 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 29922 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 4900 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 12807 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 59489 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 22332 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 18071 | 0.000 |
Why?
|
| Mutation | 1 | 2009 | 30198 | 0.000 |
Why?
|